Xenetic Biosciences, Inc.(XBIO)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Xenetic Biosciences, Inc. (XBIO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. XBIO is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $7.6m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Xenetic Biosciences, Inc. reports quarterly revenue of $660.6K, net income of $-929.7K. Top institutional holders of XBIO by reported 13-F value include RENAISSANCE TECHNOLOGIES, GEODE CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. XBIO trades on the Nasdaq exchange and files with the SEC under CIK 1534525. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate XBIO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Xenetic Biosciences, Inc. directly from SEC EDGAR.
Revenue
$660.6K
Net Income
$-929.7K
XBIO key financials by period
Xenetic Biosciences, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$3.0M
$-2.7M
-95.2%
FY 2024
10-K
$2.5M
$-4.0M
-168.2%
FY 2023
10-K
$2.5M
$-4.1M
-177.8%
FY 2022
10-K
$1.7M
$-6.6M
—
FY 2021
10-K
$1.2M
$-5.6M
—
FY 2020
10-K
$436.9K
$-10.9M
—
Institutions holding XBIO
Institutional investors reporting a position in Xenetic Biosciences, Inc. on SEC Form 13F.
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $7.6M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
